Cargando…
Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients
Cystic fibrosis (CF)–related liver disease (CFLD) is a common symptom in patients with CF. However, its prevalence, risk factors, and evolution are unclear. We analyzed a large database of patients with CF to investigate the incidence of CFLD, its related risk factors, and the use and effect of urso...
Autores principales: | Boëlle, Pierre‐Yves, Debray, Dominique, Guillot, Loic, Clement, Annick, Corvol, Harriet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519059/ https://www.ncbi.nlm.nih.gov/pubmed/30058245 http://dx.doi.org/10.1002/hep.30148 |
Ejemplares similares
-
Factors Predisposing the Response to Lumacaftor/Ivacaftor in People with Cystic Fibrosis
por: Mésinèle, Julie, et al.
Publicado: (2022) -
SLC26A9 Gene Is Associated With Lung Function Response to Ivacaftor in Patients With Cystic Fibrosis
por: Corvol, Harriet, et al.
Publicado: (2018) -
AGER -429T/C Is Associated with an Increased Lung Disease Severity in Cystic Fibrosis
por: Beucher, Julie, et al.
Publicado: (2012) -
First Wave of COVID-19 in French Patients with Cystic Fibrosis
por: Corvol, Harriet, et al.
Publicado: (2020) -
Modifier Factors of Cystic Fibrosis Phenotypes: A Focus on Modifier Genes
por: Mésinèle, Julie, et al.
Publicado: (2022)